LFWD250117P5000
- 1.50
- 0.000.00%
Lifeward Newsroom
Lake Street Maintains Lifeward(LFWD.US) With Buy Rating, Cuts Target Price to $6
ReWalk Robotics Price Target Maintained With a $13.00/Share by HC Wainwright & Co.
Lifeward Analyst Ratings
H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $13
Lake Street Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $8.5
Lake Street Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $8.5
Rewalk Robotics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)
H.C. Wainwright Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $13
Lake Street Initiates ReWalk Robotics(LFWD.US) With Buy Rating, Announces Target Price $8.5
Lake Street Remains a Buy on Rewalk Robotics (LFWD)
Rewalk Robotics Analyst Ratings
HC Wainwright & Co. Maintains Buy on Rewalk Robotics, Raises Price Target to $13
HC Wainwright & Co. : Maintaining the Rewalk Robotics (LFWD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $9.00 to $13.00.
Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Rewalk Robotics (LFWD) and Apellis Pharmaceuticals (APLS)
HC Wainwright & Co. : Rewalk Robotics (LFWD.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $9.00.
Rewalk Robotics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rewalk Robotics, Maintains $9 Price Target
HC Wainwright & Co. Reiterates Buy on Rewalk Robotics, Maintains $3 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Irhythm Technologies (IRTC), Ventyx Biosciences (VTYX) and Rewalk Robotics (LFWD)